Pasar al contenido principal

METABOLISMO Y BIOACTIVIDAD DE LOS COMPUESTOS FENOLICOS DEL ACEITE DE OLIVA EN HUMANOS. EL PROYECTO MEFOPC

AGL2012-40144-C03-01

•
Nombre agencia financiadora Ministerio de Economía y Competitividad
Acrónimo agencia financiadora MINECO
Programa Programa Nacional de Proyectos de Investigación Fundamental
Subprograma Subprograma de Proyectos de Investigación Fundamental no Orientada
Convocatoria Proyectos I+D
Año convocatoria 2012
Plan Estatal 2008-2011 Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica
Unidad de gestión Secretaría de Estado de Investigación, Desarrollo e Innovación
Centro beneficiario FUNDACIO INSTITUT HOSPITAL DEL MAR D'INVESTIGACIONS MEDIQUES
Identificador persistente http://dx.doi.org/10.13039/501100003329

Resultados relacionados

Resultados totales (Incluyendo duplicados): 27
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Impact of phenol-enriched olive oils on serum metabonome and its relationship with cardiometabolic parameters. a randomized, double-blind, cross-over, controlled trial

  • Farràs Mañé, Marta
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió, Laura
  • Subirana Cachinero, Isaac
  • Catalán, Úrsula
  • Motilva, Maria-José
  • Solà, Rosa
  • Covas Planells, Maria Isabel
  • Blanco-Vaca, Francisco
  • Fitó Colomer, Montserrat
  • Mayneris Perxachs, Jordi
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases., It was supported by the Spanish Ministry of Science and Innovation (MICINN) financing the projects AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and AGL2012-40144-C03-01. It was also supported by the Instituto de Salud Carlos III (Co-funded by the European Regional Development Fund [ERDF], a way to build Europe), financing the CIBEROBN-stay fellowship and Sara Borrell contract (CD17/00233) to M. Farràs. The PI1800164 project to F.B.-V, and the PI20/01090 project, and the Miguel Servet Program to J.M.-P. CIBERCV, CIBERDEM, and CIBEROBN are initiatives of Instituto de Salud Carlos III.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Phenol-enriched virgin olive oil promotes macrophage-specific reverse cholesterol transport in vivo

  • Cedó, Lídia
  • Fernández-Castillejo, Sara
  • Rubió, Laura
  • Metso, Jari
  • Santos, David
  • Muñoz-Aguayo, D.
  • Rivas-Urbina, Andrea
  • Tondo, Mireia
  • Méndez-Lara, Karen Alejandra
  • Farràs Mañé, Marta
  • Jauhiainen, Matti
  • Motilva, Maria-José
  • Fitó Colomer, Montserrat
  • Blanco-Vaca, Francisco
  • Solà, Rosa
  • Escolà-Gil, Joan Carles
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo., This work was partly funded by the Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grants PI14-01648 and PI18-00164 (to F.B.-V.), PI16-00139 and PI19-00136 (to J.C.E-G), and CB06/03/0028 (to M.F. (Montserrat Fitó)); by the Ministerio de Economía, Indústria y Competitividad and FEDER AppleCOR Project (subproject AGL2016-76943-C2-2-R and subproject AGL2016- 76943-C2-1-R) (to R.S.), AGL2009-13517-C03-01 and AGL2012-40144-C03-01 (to M.F. (Montserrat Fitó)); by the Agència de Gestió d’Ajuts Universitaris i de Recerca 2014-SGR-240, 2017-SGR-522, 2017-SGR-222, and 2017-BP-00021; by the Jane and Aatos Erkko Foundation (to M.J. and J.M.); and the Finnish Foundation for Cardiovascular Research (to M.J.). M.F. (Marta Farràs) has a Sara Borrell contract (CD17/00233). CIBERDEM and CIBEROBN are initiatives of the Instituto de Salud Carlos III.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes: a randomized, crossover, controlled trial

  • Farràs Mañé, Marta
  • Arranz, Sara
  • Carrión, Sílvia
  • Subirana Cachinero, Isaac
  • Muñoz-Aguayo, D.
  • Blanchart, Gemma
  • Kool, Marjon
  • Solà, Rosa
  • Motilva, Maria-José
  • Escolà-Gil, Joan Carles
  • Rubió, Laura
  • Fernández-Castillejo, Sara
  • Pedret, Anna
  • Estruch, Ramón
  • Covas Planells, Maria Isabel
  • Fitó Colomer, Montserrat
  • Hernáez, Álvaro
  • Castañer, Olga
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes., This research was funded by: the Spanish Ministry of Economy and Competitiveness (AGL2009-13517-C03-01, AGL2012-40144-C03-01), the Instituto de Salud Carlos III (CB06/03/0028, CB07/08/0016, CD17/00122, CD17/00233, and JR17/00022), FEDER funds (CB06/03), and the Agència de Gestió d’Ajuts Universitaris i de Recerca (2014-SGR-240, 2017-SGR-522).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study)

  • Pedret, Anna
  • Catalán Santos, Úrsula
  • Fernandez-Castillejo, Sara
  • Farràs, Marta
  • Valls, Rosa M.
  • Rubió Piqué, Laura
  • Canela, Núria
  • Aragonés, Gerard
  • Romeu, Marta
  • Castaner, Olga
  • De la Torre, Rafael
  • Covas Planells, María Isabel
  • Fitó, Montserrat
  • Motilva Casado, Mª José
  • Solà, Rosa
The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new aspects of cardioprotective properties, are still unknown. The aim of this study was to assess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two functional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs (FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September 2012. Thirty-three hypercholesterolemic participants (total cholesterol >200mg/dL; 19 men and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled, cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO, FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins were identified. Among these, 15 were commonly differently expressed after the three VOO interventions compared to baseline, with specific changes observed for each intervention. The 15 common proteins were mainly involved in the following pathways: LXR/RXR activation, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL proteome in a cardioprotective mode by up-regulating proteins related to cholesterol homeostasis, protection against oxidation and blood coagulation while down-regulating proteins implicated in acute-phase response, lipid transport, and immune response. The common observed protein expression modifications after the three VOOs indicate a major matrix effect., This study was supported by: the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-40144-C03-01 and AGL2012-40144-C03-03 projects and, AGL2009-13517-C03-01 and AGL2009-13517-C03-03 project), CIBEROBN, FPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100). AP is a post-graduate research student supported by the Universitat Rovira i Virgili and the Centre Tecnològic de Nutrició i Salut (CTNS).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer

  • Fernández Castillejo, Sara
  • Rubió Piqué, Laura
  • Hernáez Camba, Álvaro
  • Catalán Santos, Úrsula
  • Pedret, Anna
  • Valls, Rosa M.
  • Mosele, Juana
  • Covas Planells, María Isabel
  • Remaley, Alan T.
  • Castañer, Olga
  • Motilva Casado, Mª José
  • Solà, Rosa
Scope: Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to assess which HDL parameters were CEC determinants after virgin olive oil (VOO) ingestion. Methods and results: Post‐hoc analyses from the VOHF study, a crossover intervention with three types of VOO. We assessed the relationship of 3‐week changes in HDL‐related variables after intervention periods with independence of the type of VOO. After univariate analyses, mixed linear models were fitted with variables related with CEC and fluidity. Fluidity and Apolipoprotein (Apo)A‐I content in HDL was directly associated, and HDL oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL mean size, were associated to HDL fluidity. Conclusions: HDL fluidity, ApoA‐I concentration, and oxidative status are major determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL functionality in humans through nutritional or pharmacological interventions., This study was supported by the Spanish Ministry of Economy (MINECO) financing the projects AGL2009‐13517‐457 C03‐01, C03‐02 and C03‐3, AGL2012‐40144‐C01‐03, C02‐03 and C03‐03, and the FPI‐fellowship (BES‐2010‐040766). L.R. is Sara Borell contract (CD14/00275) co‐financed by and IISPV. U.C. is a PERIS contract (Pla estratègic de recerca i innovació en salut). A.P. is a Torres Quevedo contract (Subprograma Estatal de Incorporación, Plan Estatal de Investigación Científica y Técnica y de Innovación) co‐financed by Eurecat‐CTNS. O.C. was supported by a research contract of the ISCIII JR14/00008.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Impact of Phenol‐Enriched Virgin Olive Oils on the Postprandial Levels of Circulating microRNAs Related to Cardiovascular Disease

  • Daimiel, Lidia
  • Micó, Víctor
  • Valls, Rosa M.
  • Pedret, Anna
  • Motilva Casado, Mª José
  • Rubió Piqué, Laura
  • Fitó, Montserrat
  • Farràs, Marta
  • Covas Planells, María Isabel
  • Solà, Rosa
  • Ordovás, José M.
Scope: We investigate the postprandial modulation of cardiovascular‐related microRNAs elicited by extra virgin olive oil (EVOOs) containing different levels of their own polyphenols. Methods and results: It is randomized, postprandial, parallel, double‐blind study. Twelve healthy participants consumed 30 mL of EVOO containing low (L‐EVOO; 250 mg total phenols kg−1 of oil), medium (M‐EVOO; 500 mg total phenols kg−1 of oil), and high (H‐EVOO; 750 mg total phenols kg−1 of oil) enriched EVOOs. Postprandial plasma microRNAs levels are analyzed by real‐time quantitative PCR. The results show that L‐EVOO intake is associated with decreased let‐7e‐5p and miR‐328a‐3p levels and increased miR‐17‐5p and miR‐20a‐5p, concentrations. M‐EVOO decreases plasma let‐7e‐5p and increases miR‐17‐5p, miR‐20a‐5p, and miR‐192‐5p levels. Finally, H‐EVOO decreases let‐7e‐5p, miR‐10a‐5p, miR‐21‐5p, and miR‐26b‐5p levels. Conclusion: During the postprandial state, the levels of let‐7e‐5p decrease with EVOO regardless of polyphenol content suggesting a general response to the fatty acid composition of EVOO or/and the presence of at least 250 mg polyphenol kg−1 olive oil. Moreover, the miR‐17‐92 cluster increases by low and medium polyphenol content suggesting a role in fatty acid metabolism and nutrient sensing. Thus, postprandial modulation of circulating microRNAs levels could be a potential mechanism for the cardiovascular benefits associated with EVOO intake., The present work was funded by Fundación Salud 2000 – Merck‐Serono research fellowship granted to J.M.O. in the 2013 call V.M. was supported by a Manuel de Oya fellowship of the Fundación Cerveza y Salud. This work was supported by grants: the VOHF Study (AGL2009‐13517‐C03), the MEFOPC Project (AGL2012‐40144‐C03) from the Spanish Ministry of Education and Science and the grants PI14/01374 and PI17/00508 granted to L.D. by Instituto de Salud Carlos III through the Fondo de Investigación para la Salud (FIS), which is co‐funded by the European Regional Development Fund. A.P. has Torres Quevedo contract (Subprograma Estatal de Incorporación, Plan Estatal de Investigación Científica y Técnica y de Innovación).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota

  • Martín Peláez, Sandra María
  • Mosele, Juana
  • Pizarro, Neus
  • Farràs, Marta
  • De la Torre, Rafael
  • Subirana Cachinero, Isaac
  • Pérez Cano, Francisco José
  • Castañer, Olga
  • Solà, Rosa
  • Fernández Castillejo, Sara
  • Heredia, Saray
  • Farré, Magí
  • Motilva Casado, Mª José
  • Fitó, Montserrat
Purpose: To investigate the effect of virgin olive oil phenolic compounds (PC) alone or in combination with thyme PC on blood lipid profile from hypercholesterolemic humans, and whether the changes generated are related with changes in gut microbiota populations and activities. Methods: A randomized, controlled, double-blind, crossover human trial (n = 12) was carried out. Participants ingested 25 mL/day for 3 weeks, preceded by 2-week washout periods, three raw virgin olive oils differing in the concentration and origin of PC: (1) a virgin olive oil (OO) naturally containing 80 mg PC/kg, (VOO), (2) a PC-enriched virgin olive oil containing 500 mg PC/kg, from OO (FVOO), and (3) a PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme, 1:1 (FVOOT). Blood lipid values and faecal quantitative changes in microbial populations, short chain fatty acids, cholesterol microbial metabolites, bile acids, and phenolic metabolites were analysed. Results: FVOOT decreased seric ox-LDL concentrations compared with pre-FVOOT, and increased numbers of bifidobacteria and the levels of the phenolic metabolite protocatechuic acid compared to VOO (P < 0.05). FVOO did not lead to changes in blood lipid profile nor quantitative changes in the microbial populations analysed, but increased the coprostanone compared to FVOOT (P < 0.05), and the levels of the faecal hydroxytyrosol and dihydroxyphenylacetic acids, compared with pre-intervention values and to VOO, respectively (P < 0.05). Conclusion: The ingestion of a PC-enriched virgin olive oil, containing a mixture of olive oil and thyme PC for 3 weeks, decreases blood ox-LDL in hypercholesterolemic humans. This cardio-protective effect could be mediated by the increases in populations of bifidobacteria together with increases in PC microbial metabolites with antioxidant activities., This work was supported by Instituto de Salud Carlos III FEDER (CB06/03/0028, CD10/00224, CP06/00100, CA11/00215), Ministry of Economy and Competitiveness (AGL2012-40144-C03-01, AGL2012-40144-C03-02, AGL2012-40144-C03-03, FPI:BES-2010-040766), Agency for Management of University and Research Grants (2009 SGR 1195).
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial

  • Fernández Castillejo, Sara
  • García Heredia, Ana Isabel
  • Solà, Rosa
  • Camps, Jordi
  • López de las Hazas Mingo, María del Carmen
  • Farràs, Marta
  • Pedret, Anna
  • Catalán Santos, Úrsula
  • Rubió Piqué, Laura
  • Motilva Casado, Mª José
  • Castañer, Olga
  • Covas Planells, María Isabel
  • Valls, Rosa M.
Scope:Low paraoxonase (PON)1 activities, and high PON1 and low PON3 protein levels arecharacteristic of cardiovascular disease. Our aim was to assess short- and long-term effects ofvirgin olive oils (VOO), enriched with their own phenolic compounds (PC; FVOO) or with themplus complementary PC from thyme (FVOOT), on PON-related variables and the mechanismsinvolved.Methods and results:Two randomized, controlled, double-blind, and crossover interventionswere conducted. In an acute intake study, participants ingested three FVOOs differing in PCcontent. In a sustained intake study, participants ingested a control VOO and two differentFVOOs with the same PC content but differing in PC source. Acute and sustained intake ofVOO and FVOO decreased PON1 protein and increased PON1-associated specific activities,while FVOOT yielded opposite results. PON3 protein levels increased only after sustainedconsumption of VOO. Mechanistic studies performed in rat livers showed that intake of isolatedPC from VOO and from thyme modulate mitogen-activated protein kinases and peroxisomeproliferator-activated receptors regulating PON synthesis, while a combination of these PCscancels such regulation.Conclusion:This study reveals that the intake of phenol-enriched FVOOs modulates oxidativebalance by modifying PON-related variables according to PC content and source, and thismodulation can be perceived as beneficial., This study was supported by the Spanish Ministry of Econ-omy (MINECO) financing the projects AGL2009-13517-457-C03-01, C03-02 and C03-3, AGL2012-40144-C01-03, C02-03 and C03-03, and the FPI-fellowship (BES-2010-040766), byC©2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimwww.mnf-journal.com 1600932 (11 of 13)S. Fern ́andez-Castillejo et al.Mol. Nutr. Food Res. 61,10, 2017, 1600932a contract from the Catalan Government, and by grants fromISCIII FEDER (CB06/03/0028), AGAUR(2014SGR240) andAGAUR (2014SGR783). AP is a Torres Quevedo contract (PTQ-15-08068; Subprograma Estatal de Incorporaci ́on, Plan Estatalde Investigaci ́on Cient ́ıfica y T ́ecnica y de Innovaci ́on). UC is aPERIS contract (SLT002/16/00239; Pla estrat`egic de recerca iinnovaci ́o en salut). LR is Sara Borell contract (CD14/00275)co-financed by and IISPV. OC was supported by a research con-tract of Carlos III (SCIII JR14/00008). Thanks to the Universityof Lleida for the M-CLH PhD. grant.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Impact of phenol-enriched olive oils on serum metabonome and its relationship with cardiometabolic parameters: a randomized, deouble-blind, cross-over, controlled trial

  • Farràs, Marta
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió Piqué, Laura
  • Subirana, Isaac
  • Catalán, Úrsula
  • Motilva Casado, Mª José
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases., It was supported by the Spanish Ministry of Science and Innovation (MICINN) financing the projects AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and AGL2012-40144-C03-01. It was also supported by the Instituto de Salud Carlos III (Co-funded by the European Regional Development Fund [ERDF], a way to build Europe), financing the CIBEROBN-stay fellowship and Sara Borrell contract (CD17/00233) to M. Farràs. The PI1800164 project to F.B.-V, and the PI20/01090 project, and the Miguel Servet Program to J.M.-P. CIBERCV, CIBERDEM, and CIBEROBN are initiatives of Instituto de Salud Carlos III.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Virgin olive oil enriched with its own phenolic compounds or complemented with thyme improves endothelial function: The potential role of plasmatic fat-soluble vitamins. A double blind, randomized, controlled, cross-over clinical trial

  • Valls, Rosa M.
  • Farràs, Marta
  • Pedret, Anna
  • Fernández Castillejo, Sara
  • Catalán Santos, Úrsula
  • Romeu, Marta
  • Giralt, Montserrat
  • Sáez, Guillermo T.
  • Fitó, Montserrat
  • De la Torre, Rafael
  • Covas Planells, María Isabel
  • Motilva Casado, Mª José
  • Solà, Rosa
  • Rubió Piqué, Laura
The aim of the present study was to assess whether different functional virgin olive oils (FVOOs) with varying phenolic compounds (PC) could protect the plasmatic fat-soluble vitamins, which in turn could improve the endothelial function. In order to select the optimal phenolic dose in the improvement of ischemic reactive hyperemia (IRH), a dose-response study (n = 12, healthy subjects) was performed and the enrichment of 500 mg PC/kg oil was selected. In a 3-week cross-over sustained study (n = 33 hypercholesterolemic subjects), the consumption of 25 mL/day of two phenol-enriched olive oils (one enriched with its own PC and another combined with thyme PC) increased IRH and plasma concentrations of retinol, β-cryptoxanthin and α-tocopherol, compared to a control virgin olive oil. A positive post-intervention correlation was observed for IRH values and HDL-c, β-cryptoxanthin, lutein and α-tocopherol. Results suggest that preservation of plasmatic fat-soluble vitamins by PC from FVOOS could partially explain the endothelial function benefits., This study was supported by the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-4014-C03-01 and AGL2012-40144-C03-03 projects and AGL2009-13517-C03-01, AGL2009-13517-C03-02 and AGL2009-13517-C03-03 project), CIBEROBN, FPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100). PI13/01848, integrado en el Plan Estatal de I+D+I 2013-2016 y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER). We thank Borges Mediterranean Group for providing the common olive oil used in the study. This work has been done in the context of Universitat Autònoma de Barcelona (UAB) PhD Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology. Authors’ contributions to manuscript were as following: R-MV, MFi, RdlT, M-IC, M-JM, RS design research; R-MV, MFa, AP,SF-C, UC, LR, MR, MG, GT-S, MFi, RdlT, M-IC, M-JM, RS were responsible for the execution of the study including hands-on conduct of the experiments, data collection and interpretation of data; R-MV, AP, RS, LR drafted the manuscript and MFi, M-IC, M-JM, RS, LR revised the manuscript critically providing important intellectual content. RS has primary responsibility for final content. All the authors read and approved the final manuscript.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Faecal microbial metabolism of olive oil phenolic compounds: in-vitro and in-vivo approaches

  • Mosele, Juana
  • Martín Peláez, Sandra María
  • Macià i Puig, Ma Alba
  • Farràs, Marta
  • Valls, Rosa M.
  • Catalán Santos, Úrsula
  • Motilva Casado, Mª José
In the present study, the individual colonic metabolism of the main components of the virgin olive oil phenolic fraction was evaluated by an in vitro model using human faecal microbiota. To assess differences in metabolism related to the molecular structure, four phenolic standards were selected, tyrosol, hydroxytyrosol, hydroxytyrosol acetate and oleuropein. After studying the in vitro colonic metabolism pathways of the individual phenols, the presence of their colonic metabolites was investigated in human faecal samples obtained before and after the sustained intake (3 weeks) of a daily dose of 25 mL of a phenol-enriched olive oil., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (AGL2009–13517-C03, AGL2012–40144-C03–03, AGL2012–40144-C03–02 and AGL2012–40144-C03–01 projects); Spanish Ministry of Health (FIS-FEDER; PI021307), CIBERDEM and CIBEROBN (CB06/03); Health Institute of Carlos III (Sara Borrell CD10/00224); Generalitat de Catalunya through the J. Mosele grant, and the FPI contract (BES-2010–040766) through the M Farràs grant in the context of Autonomous University of Barcelona (UAB) Ph.D. Program in Biochemistry, Molecular Biology and Biomedicine.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo

  • Cedó Giné, Lídia
  • Fernández Castillejo, Sara
  • Rubió Piqué, Laura
  • Metso, Jari
  • Santos, David
  • Muñoz-Aguayo, Daniel
  • Rivas-Urbina, Andrea
  • Tondo i Colomer, Mireia
  • Méndez Lara, Karen Alejandra
  • Farràs, Marta
  • Jauhiainen, Matti
  • Motilva Casado, Mª José
  • Fitó, Montserrat
  • Blanco Vaca, Francisco
  • Solà, Rosa
  • Escolà Gil, Joan Carles
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo., This work was partly funded by the Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grants PI14-01648 and PI18-00164 (to F.B.-V.), PI16-00139 and PI19-00136 (to J.C.E-G), and CB06/03/0028 (to M.F. (Montserrat Fitó)); by the Ministerio de Economía, Indústria y Competitividad and FEDER AppleCOR Project (subproject AGL2016-76943-C2-2-R and subproject AGL2016- 76943-C2-1-R) (to R.S.), AGL2009-13517-C03-01 and AGL2012-40144-C03-01 (to M.F. (Montserrat Fitó)); by the Agència de Gestió d’Ajuts Universitaris i de Recerca 2014-SGR-240, 2017-SGR-522, 2017-SGR-222, and 2017-BP-00021; by the Jane and Aatos Erkko Foundation (to M.J. and J.M.); and the Finnish Foundation for Cardiovascular Research (to M.J.). M.F. (Marta Farràs) has a Sara Borrell contract (CD17/00233). CIBERDEM and CIBEROBN are initiatives of the Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo

  • Cedó Giné, Lídia
  • Fernández Castillejo, Sara
  • Rubió Piqué, Laura
  • Metso, Jari
  • Santos, David
  • Muñoz-Aguayo, Daniel
  • Rivas-Urbina, Andrea
  • Tondo i Colomer, Mireia
  • Méndez Lara, Karen Alejandra
  • Farràs, Marta
  • Jauhiainen, Matti
  • Motilva Casado, Mª José
  • Fitó, Montserrat
  • Blanco Vaca, Francisco
  • Solà, Rosa
  • Escolà Gil, Joan Carles
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo., This work was partly funded by the Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grants PI14-01648 and PI18-00164 (to F.B.-V.), PI16-00139 and PI19-00136 (to J.C.E-G), and CB06/03/0028 (to M.F. (Montserrat Fitó)); by the Ministerio de Economía, Indústria y Competitividad and FEDER AppleCOR Project (subproject AGL2016-76943-C2-2-R and subproject AGL2016- 76943-C2-1-R) (to R.S.), AGL2009-13517-C03-01 and AGL2012-40144-C03-01 (to M.F. (Montserrat Fitó)); by the Agència de Gestió d’Ajuts Universitaris i de Recerca 2014-SGR-240, 2017-SGR-522, 2017-SGR-222, and 2017-BP-00021; by the Jane and Aatos Erkko Foundation (to M.J. and J.M.); and the Finnish Foundation for Cardiovascular Research (to M.J.). M.F. (Marta Farràs) has a Sara Borrell contract (CD17/00233). CIBERDEM and CIBEROBN are initiatives of the Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study)

  • Pedret, Anna
  • Catalán Santos, Úrsula
  • Fernandez-Castillejo, Sara
  • Farràs, Marta
  • Valls, Rosa M.
  • Rubió Piqué, Laura
  • Canela, Núria
  • Aragonés, Gerard
  • Romeu, Marta
  • Castaner, Olga
  • De la Torre, Rafael
  • Covas Planells, María Isabel
  • Fitó, Montserrat
  • Motilva Casado, Mª José
  • Solà, Rosa
The effects of olive oil phenolic compounds (PCs) on HDL proteome, with respect to new aspects of cardioprotective properties, are still unknown. The aim of this study was to assess the impact on the HDL protein cargo of the intake of virgin olive oil (VOO) and two functional VOOs, enriched with their own PCs (FVOO) or complemented with thyme PCs (FVOOT), in hypercholesterolemic subjects. Eligible volunteers were recruited from the IMIM-Hospital del Mar Medical Research Institute (Spain) from April 2012 to September 2012. Thirty-three hypercholesterolemic participants (total cholesterol >200mg/dL; 19 men and 14 women; aged 35 to 80 years) were randomized in the double-blind, controlled, cross-over VOHF clinical trial. The subjects received for 3 weeks 25 mL/day of: VOO, FVOO, or FVOOT. Using a quantitative proteomics approach, 127 HDL-associated proteins were identified. Among these, 15 were commonly differently expressed after the three VOO interventions compared to baseline, with specific changes observed for each intervention. The 15 common proteins were mainly involved in the following pathways: LXR/RXR activation, acute phase response, and atherosclerosis. The three VOOs were well tolerated by all participants. Consumption of VOO, or phenol-enriched VOOs, has an impact on the HDL proteome in a cardioprotective mode by up-regulating proteins related to cholesterol homeostasis, protection against oxidation and blood coagulation while down-regulating proteins implicated in acute-phase response, lipid transport, and immune response. The common observed protein expression modifications after the three VOOs indicate a major matrix effect., This study was supported by: the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-40144-C03-01 and AGL2012-40144-C03-03 projects and, AGL2009-13517-C03-01 and AGL2009-13517-C03-03 project), CIBEROBN, FPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100). AP is a post-graduate research student supported by the Universitat Rovira i Virgili and the Centre Tecnològic de Nutrició i Salut (CTNS).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of phenol-enriched olive oils on serum metabonome and its relationship with cardiometabolic parameters. a randomized, double-blind, cross-over, controlled trial

  • Farràs Mañé, Marta
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió, Laura
  • Subirana Cachinero, Isaac
  • Catalán, Úrsula
  • Motilva, Maria-José
  • Solà, Rosa
  • Covas Planells, Maria Isabel
  • Blanco-Vaca, Francisco
  • Fitó Colomer, Montserrat
  • Mayneris Perxachs, Jordi
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases., It was supported by the Spanish Ministry of Science and Innovation (MICINN) financing the projects AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and AGL2012-40144-C03-01. It was also supported by the Instituto de Salud Carlos III (Co-funded by the European Regional Development Fund [ERDF], a way to build Europe), financing the CIBEROBN-stay fellowship and Sara Borrell contract (CD17/00233) to M. Farràs. The PI1800164 project to F.B.-V, and the PI20/01090 project, and the Miguel Servet Program to J.M.-P. CIBERCV, CIBERDEM, and CIBEROBN are initiatives of Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of Phenol‐Enriched Virgin Olive Oils on the Postprandial Levels of Circulating microRNAs Related to Cardiovascular Disease

  • Daimiel, Lidia
  • Micó, Víctor
  • Valls, Rosa M.
  • Pedret, Anna
  • Motilva Casado, Mª José
  • Rubió Piqué, Laura
  • Fitó, Montserrat
  • Farràs, Marta
  • Covas Planells, María Isabel
  • Solà, Rosa
  • Ordovás, José M.
Scope: We investigate the postprandial modulation of cardiovascular‐related microRNAs elicited by extra virgin olive oil (EVOOs) containing different levels of their own polyphenols. Methods and results: It is randomized, postprandial, parallel, double‐blind study. Twelve healthy participants consumed 30 mL of EVOO containing low (L‐EVOO; 250 mg total phenols kg−1 of oil), medium (M‐EVOO; 500 mg total phenols kg−1 of oil), and high (H‐EVOO; 750 mg total phenols kg−1 of oil) enriched EVOOs. Postprandial plasma microRNAs levels are analyzed by real‐time quantitative PCR. The results show that L‐EVOO intake is associated with decreased let‐7e‐5p and miR‐328a‐3p levels and increased miR‐17‐5p and miR‐20a‐5p, concentrations. M‐EVOO decreases plasma let‐7e‐5p and increases miR‐17‐5p, miR‐20a‐5p, and miR‐192‐5p levels. Finally, H‐EVOO decreases let‐7e‐5p, miR‐10a‐5p, miR‐21‐5p, and miR‐26b‐5p levels. Conclusion: During the postprandial state, the levels of let‐7e‐5p decrease with EVOO regardless of polyphenol content suggesting a general response to the fatty acid composition of EVOO or/and the presence of at least 250 mg polyphenol kg−1 olive oil. Moreover, the miR‐17‐92 cluster increases by low and medium polyphenol content suggesting a role in fatty acid metabolism and nutrient sensing. Thus, postprandial modulation of circulating microRNAs levels could be a potential mechanism for the cardiovascular benefits associated with EVOO intake., The present work was funded by Fundación Salud 2000 – Merck‐Serono research fellowship granted to J.M.O. in the 2013 call V.M. was supported by a Manuel de Oya fellowship of the Fundación Cerveza y Salud. This work was supported by grants: the VOHF Study (AGL2009‐13517‐C03), the MEFOPC Project (AGL2012‐40144‐C03) from the Spanish Ministry of Education and Science and the grants PI14/01374 and PI17/00508 granted to L.D. by Instituto de Salud Carlos III through the Fondo de Investigación para la Salud (FIS), which is co‐funded by the European Regional Development Fund. A.P. has Torres Quevedo contract (Subprograma Estatal de Incorporación, Plan Estatal de Investigación Científica y Técnica y de Innovación).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Faecal microbial metabolism of olive oil phenolic compounds: in-vitro and in-vivo approaches

  • Mosele, Juana
  • Martín Peláez, Sandra María
  • Macià i Puig, Ma Alba
  • Farràs, Marta
  • Valls, Rosa M.
  • Catalán Santos, Úrsula
  • Motilva Casado, Mª José
In the present study, the individual colonic metabolism of the main components of the virgin olive oil phenolic fraction was evaluated by an in vitro model using human faecal microbiota. To assess differences in metabolism related to the molecular structure, four phenolic standards were selected, tyrosol, hydroxytyrosol, hydroxytyrosol acetate and oleuropein. After studying the in vitro colonic metabolism pathways of the individual phenols, the presence of their colonic metabolites was investigated in human faecal samples obtained before and after the sustained intake (3 weeks) of a daily dose of 25 mL of a phenol-enriched olive oil., This work was supported by the Spanish Ministry of Economy and Competitiveness (MINECO) (AGL2009–13517-C03, AGL2012–40144-C03–03, AGL2012–40144-C03–02 and AGL2012–40144-C03–01 projects); Spanish Ministry of Health (FIS-FEDER; PI021307), CIBERDEM and CIBEROBN (CB06/03); Health Institute of Carlos III (Sara Borrell CD10/00224); Generalitat de Catalunya through the J. Mosele grant, and the FPI contract (BES-2010–040766) through the M Farràs grant in the context of Autonomous University of Barcelona (UAB) Ph.D. Program in Biochemistry, Molecular Biology and Biomedicine.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Virgin olive oil enriched with its own phenolic compounds or complemented with thyme improves endothelial function: The potential role of plasmatic fat-soluble vitamins. A double blind, randomized, controlled, cross-over clinical trial

  • Valls, Rosa M.
  • Farràs, Marta
  • Pedret, Anna
  • Fernández Castillejo, Sara
  • Catalán Santos, Úrsula
  • Romeu, Marta
  • Giralt, Montserrat
  • Sáez, Guillermo T.
  • Fitó, Montserrat
  • De la Torre, Rafael
  • Covas Planells, María Isabel
  • Motilva Casado, Mª José
  • Solà, Rosa
  • Rubió Piqué, Laura
The aim of the present study was to assess whether different functional virgin olive oils (FVOOs) with varying phenolic compounds (PC) could protect the plasmatic fat-soluble vitamins, which in turn could improve the endothelial function. In order to select the optimal phenolic dose in the improvement of ischemic reactive hyperemia (IRH), a dose-response study (n = 12, healthy subjects) was performed and the enrichment of 500 mg PC/kg oil was selected. In a 3-week cross-over sustained study (n = 33 hypercholesterolemic subjects), the consumption of 25 mL/day of two phenol-enriched olive oils (one enriched with its own PC and another combined with thyme PC) increased IRH and plasma concentrations of retinol, β-cryptoxanthin and α-tocopherol, compared to a control virgin olive oil. A positive post-intervention correlation was observed for IRH values and HDL-c, β-cryptoxanthin, lutein and α-tocopherol. Results suggest that preservation of plasmatic fat-soluble vitamins by PC from FVOOS could partially explain the endothelial function benefits., This study was supported by the Ministerio de Economia y Competitividad (AGL2012-40144-C03-02; AGL2012-4014-C03-01 and AGL2012-40144-C03-03 projects and AGL2009-13517-C03-01, AGL2009-13517-C03-02 and AGL2009-13517-C03-03 project), CIBEROBN, FPI fellowship (BES-2010-040766), ISCIII and Departament de Salut joint contract (CP06/00100). PI13/01848, integrado en el Plan Estatal de I+D+I 2013-2016 y cofinanciado por el ISCIII-Subdirección General de Evaluación y el Fondo Europeo de Desarrollo Regional (FEDER). We thank Borges Mediterranean Group for providing the common olive oil used in the study. This work has been done in the context of Universitat Autònoma de Barcelona (UAB) PhD Program in Biochemistry, Molecular Biology and Biomedicine, Department of Biochemistry and Molecular Biology. Authors’ contributions to manuscript were as following: R-MV, MFi, RdlT, M-IC, M-JM, RS design research; R-MV, MFa, AP,SF-C, UC, LR, MR, MG, GT-S, MFi, RdlT, M-IC, M-JM, RS were responsible for the execution of the study including hands-on conduct of the experiments, data collection and interpretation of data; R-MV, AP, RS, LR drafted the manuscript and MFi, M-IC, M-JM, RS, LR revised the manuscript critically providing important intellectual content. RS has primary responsibility for final content. All the authors read and approved the final manuscript.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenol-enriched virgin olive oil promotes macrophage-specific reverse cholesterol transport in vivo

  • Cedó, Lídia
  • Fernández-Castillejo, Sara
  • Rubió, Laura
  • Metso, Jari
  • Santos, David
  • Muñoz-Aguayo, D.
  • Rivas-Urbina, Andrea
  • Tondo, Mireia
  • Méndez-Lara, Karen Alejandra
  • Farràs Mañé, Marta
  • Jauhiainen, Matti
  • Motilva, Maria-José
  • Fitó Colomer, Montserrat
  • Blanco-Vaca, Francisco
  • Solà, Rosa
  • Escolà-Gil, Joan Carles
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [3H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassettea1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo., This work was partly funded by the Instituto de Salud Carlos III and FEDER “Una manera de hacer Europa” grants PI14-01648 and PI18-00164 (to F.B.-V.), PI16-00139 and PI19-00136 (to J.C.E-G), and CB06/03/0028 (to M.F. (Montserrat Fitó)); by the Ministerio de Economía, Indústria y Competitividad and FEDER AppleCOR Project (subproject AGL2016-76943-C2-2-R and subproject AGL2016- 76943-C2-1-R) (to R.S.), AGL2009-13517-C03-01 and AGL2012-40144-C03-01 (to M.F. (Montserrat Fitó)); by the Agència de Gestió d’Ajuts Universitaris i de Recerca 2014-SGR-240, 2017-SGR-522, 2017-SGR-222, and 2017-BP-00021; by the Jane and Aatos Erkko Foundation (to M.J. and J.M.); and the Finnish Foundation for Cardiovascular Research (to M.J.). M.F. (Marta Farràs) has a Sara Borrell contract (CD17/00233). CIBERDEM and CIBEROBN are initiatives of the Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer

  • Fernández Castillejo, Sara
  • Rubió Piqué, Laura
  • Hernáez Camba, Álvaro
  • Catalán Santos, Úrsula
  • Pedret, Anna
  • Valls, Rosa M.
  • Mosele, Juana
  • Covas Planells, María Isabel
  • Remaley, Alan T.
  • Castañer, Olga
  • Motilva Casado, Mª José
  • Solà, Rosa
Scope: Cholesterol efflux capacity of HDL (CEC) is inversely associated with cardiovascular risk. HDL composition, fluidity, oxidation, and size are related with CEC. We aimed to assess which HDL parameters were CEC determinants after virgin olive oil (VOO) ingestion. Methods and results: Post‐hoc analyses from the VOHF study, a crossover intervention with three types of VOO. We assessed the relationship of 3‐week changes in HDL‐related variables after intervention periods with independence of the type of VOO. After univariate analyses, mixed linear models were fitted with variables related with CEC and fluidity. Fluidity and Apolipoprotein (Apo)A‐I content in HDL was directly associated, and HDL oxidative status inversely, with CEC. A reduction in free cholesterol, an increase in triglycerides in HDL, and a decrease in small HDL particle number or an increase in HDL mean size, were associated to HDL fluidity. Conclusions: HDL fluidity, ApoA‐I concentration, and oxidative status are major determinants for CEC after VOO. The impact on CEC of changes in free cholesterol and triglycerides in HDL, and those of small HDL or HDL mean size, could be mechanistically linked through HDL fluidity. Our work points out novel therapeutic targets to improve HDL functionality in humans through nutritional or pharmacological interventions., This study was supported by the Spanish Ministry of Economy (MINECO) financing the projects AGL2009‐13517‐457 C03‐01, C03‐02 and C03‐3, AGL2012‐40144‐C01‐03, C02‐03 and C03‐03, and the FPI‐fellowship (BES‐2010‐040766). L.R. is Sara Borell contract (CD14/00275) co‐financed by and IISPV. U.C. is a PERIS contract (Pla estratègic de recerca i innovació en salut). A.P. is a Torres Quevedo contract (Subprograma Estatal de Incorporación, Plan Estatal de Investigación Científica y Técnica y de Innovación) co‐financed by Eurecat‐CTNS. O.C. was supported by a research contract of the ISCIII JR14/00008.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Impact of phenol-enriched olive oils on serum metabonome and its relationship with cardiometabolic parameters: a randomized, deouble-blind, cross-over, controlled trial

  • Farràs, Marta
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió Piqué, Laura
  • Subirana, Isaac
  • Catalán, Úrsula
  • Motilva Casado, Mª José
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases., It was supported by the Spanish Ministry of Science and Innovation (MICINN) financing the projects AGL2009-13517-C03-01, AGL2009-13517-C03-02, AGL2009-13517-C03-03, and AGL2012-40144-C03-01. It was also supported by the Instituto de Salud Carlos III (Co-funded by the European Regional Development Fund [ERDF], a way to build Europe), financing the CIBEROBN-stay fellowship and Sara Borrell contract (CD17/00233) to M. Farràs. The PI1800164 project to F.B.-V, and the PI20/01090 project, and the Miguel Servet Program to J.M.-P. CIBERCV, CIBERDEM, and CIBEROBN are initiatives of Instituto de Salud Carlos III.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Effect of virgin olive oil and thyme phenolic compounds on blood lipid profile: implications of human gut microbiota

  • Martín Peláez, Sandra María
  • Mosele, Juana
  • Pizarro, Neus
  • Farràs, Marta
  • De la Torre, Rafael
  • Subirana Cachinero, Isaac
  • Pérez Cano, Francisco José
  • Castañer, Olga
  • Solà, Rosa
  • Fernández Castillejo, Sara
  • Heredia, Saray
  • Farré, Magí
  • Motilva Casado, Mª José
  • Fitó, Montserrat
Purpose: To investigate the effect of virgin olive oil phenolic compounds (PC) alone or in combination with thyme PC on blood lipid profile from hypercholesterolemic humans, and whether the changes generated are related with changes in gut microbiota populations and activities. Methods: A randomized, controlled, double-blind, crossover human trial (n = 12) was carried out. Participants ingested 25 mL/day for 3 weeks, preceded by 2-week washout periods, three raw virgin olive oils differing in the concentration and origin of PC: (1) a virgin olive oil (OO) naturally containing 80 mg PC/kg, (VOO), (2) a PC-enriched virgin olive oil containing 500 mg PC/kg, from OO (FVOO), and (3) a PC-enriched virgin olive oil containing a mixture of 500 mg PC/kg from OO and thyme, 1:1 (FVOOT). Blood lipid values and faecal quantitative changes in microbial populations, short chain fatty acids, cholesterol microbial metabolites, bile acids, and phenolic metabolites were analysed. Results: FVOOT decreased seric ox-LDL concentrations compared with pre-FVOOT, and increased numbers of bifidobacteria and the levels of the phenolic metabolite protocatechuic acid compared to VOO (P < 0.05). FVOO did not lead to changes in blood lipid profile nor quantitative changes in the microbial populations analysed, but increased the coprostanone compared to FVOOT (P < 0.05), and the levels of the faecal hydroxytyrosol and dihydroxyphenylacetic acids, compared with pre-intervention values and to VOO, respectively (P < 0.05). Conclusion: The ingestion of a PC-enriched virgin olive oil, containing a mixture of olive oil and thyme PC for 3 weeks, decreases blood ox-LDL in hypercholesterolemic humans. This cardio-protective effect could be mediated by the increases in populations of bifidobacteria together with increases in PC microbial metabolites with antioxidant activities., This work was supported by Instituto de Salud Carlos III FEDER (CB06/03/0028, CD10/00224, CP06/00100, CA11/00215), Ministry of Economy and Competitiveness (AGL2012-40144-C03-01, AGL2012-40144-C03-02, AGL2012-40144-C03-03, FPI:BES-2010-040766), Agency for Management of University and Research Grants (2009 SGR 1195).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes: a randomized, crossover, controlled trial

  • Farràs Mañé, Marta
  • Arranz, Sara
  • Carrión, Sílvia
  • Subirana Cachinero, Isaac
  • Muñoz-Aguayo, D.
  • Blanchart, Gemma
  • Kool, Marjon
  • Solà, Rosa
  • Motilva, Maria-José
  • Escolà-Gil, Joan Carles
  • Rubió, Laura
  • Fernández-Castillejo, Sara
  • Pedret, Anna
  • Estruch, Ramón
  • Covas Planells, Maria Isabel
  • Fitó Colomer, Montserrat
  • Hernáez, Álvaro
  • Castañer, Olga
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes., This research was funded by: the Spanish Ministry of Economy and Competitiveness (AGL2009-13517-C03-01, AGL2012-40144-C03-01), the Instituto de Salud Carlos III (CB06/03/0028, CB07/08/0016, CD17/00122, CD17/00233, and JR17/00022), FEDER funds (CB06/03), and the Agència de Gestió d’Ajuts Universitaris i de Recerca (2014-SGR-240, 2017-SGR-522).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Phenol-enriched olive oils modify paraoxonase-related variables: A randomized, crossover, controlled trial

  • Fernández Castillejo, Sara
  • García Heredia, Ana Isabel
  • Solà, Rosa
  • Camps, Jordi
  • López de las Hazas Mingo, María del Carmen
  • Farràs, Marta
  • Pedret, Anna
  • Catalán Santos, Úrsula
  • Rubió Piqué, Laura
  • Motilva Casado, Mª José
  • Castañer, Olga
  • Covas Planells, María Isabel
  • Valls, Rosa M.
Scope:Low paraoxonase (PON)1 activities, and high PON1 and low PON3 protein levels arecharacteristic of cardiovascular disease. Our aim was to assess short- and long-term effects ofvirgin olive oils (VOO), enriched with their own phenolic compounds (PC; FVOO) or with themplus complementary PC from thyme (FVOOT), on PON-related variables and the mechanismsinvolved.Methods and results:Two randomized, controlled, double-blind, and crossover interventionswere conducted. In an acute intake study, participants ingested three FVOOs differing in PCcontent. In a sustained intake study, participants ingested a control VOO and two differentFVOOs with the same PC content but differing in PC source. Acute and sustained intake ofVOO and FVOO decreased PON1 protein and increased PON1-associated specific activities,while FVOOT yielded opposite results. PON3 protein levels increased only after sustainedconsumption of VOO. Mechanistic studies performed in rat livers showed that intake of isolatedPC from VOO and from thyme modulate mitogen-activated protein kinases and peroxisomeproliferator-activated receptors regulating PON synthesis, while a combination of these PCscancels such regulation.Conclusion:This study reveals that the intake of phenol-enriched FVOOs modulates oxidativebalance by modifying PON-related variables according to PC content and source, and thismodulation can be perceived as beneficial., This study was supported by the Spanish Ministry of Econ-omy (MINECO) financing the projects AGL2009-13517-457-C03-01, C03-02 and C03-3, AGL2012-40144-C01-03, C02-03 and C03-03, and the FPI-fellowship (BES-2010-040766), byC©2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheimwww.mnf-journal.com 1600932 (11 of 13)S. Fern ́andez-Castillejo et al.Mol. Nutr. Food Res. 61,10, 2017, 1600932a contract from the Catalan Government, and by grants fromISCIII FEDER (CB06/03/0028), AGAUR(2014SGR240) andAGAUR (2014SGR783). AP is a Torres Quevedo contract (PTQ-15-08068; Subprograma Estatal de Incorporaci ́on, Plan Estatalde Investigaci ́on Cient ́ıfica y T ́ecnica y de Innovaci ́on). UC is aPERIS contract (SLT002/16/00239; Pla estrat`egic de recerca iinnovaci ́o en salut). LR is Sara Borell contract (CD14/00275)co-financed by and IISPV. OC was supported by a research con-tract of Carlos III (SCIII JR14/00008). Thanks to the Universityof Lleida for the M-CLH PhD. grant.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Phenol-Enriched Virgin Olive Oil Promotes Macrophage-Specific Reverse Cholesterol Transport In Vivo

  • Cedó, Lídia|||0000-0003-4354-3411
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Rubió, Laura
  • Metso, Jari
  • Santos, David|||0000-0003-1157-4969
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Rivas-Urbina, Andrea|||0000-0002-0111-0477
  • Tondo Colomer, Mireia|||0000-0002-0301-9984
  • Méndez Lara, Karen Alejandra|||0000-0002-8372-2310
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Jauhiainen, Matti|||0000-0002-3836-3785
  • Motilva, Maria-José|||0000-0001-8985-7737
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Solà, Rosa|||0000-0002-8359-235X
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
The intake of olive oil (OO) enriched with phenolic compounds (PCs) promotes ex vivo HDL-mediated macrophage cholesterol efflux in humans. We aimed to determine the effects of PC-enriched virgin OO on reverse cholesterol transport (RevCT) from macrophages to feces in vivo. Female C57BL/6 mice were given intragastric doses of refined OO (ROO) and a functional unrefined virgin OO enriched with its own PC (FVOO) for 14 days. Our experiments included two independent groups of mice that received intragastric doses of the phenolic extract (PE) used to prepare the FVOO and the vehicle solution (saline), as control, for 14 days. FVOO intake led to a significant increase in serum HDL cholesterol and its ability to induce macrophage cholesterol efflux in vitro when compared with ROO group. This was concomitant with the enhanced macrophage-derived [ 3 H]cholesterol transport to feces in vivo. PE intake per se also increased HDL cholesterol levels and significantly promoted in vivo macrophage-to-feces RevCT rate when compared with saline group. PE upregulated the expression of the main macrophage transporter involved in macrophage cholesterol efflux, the ATP binding cassette a1. Our data provide direct evidence of the crucial role of OO PCs in the induction of macrophage-specific RevCT in vivo.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters, A Randomized, Double-Blind, Cross-Over, Controlled Trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Swann, Jonathan Richard
  • Rowland, Ian
  • Rubió, Laura
  • Subirana, Isaac|||0000-0003-1676-0197
  • Catalán, Úrsula
  • Motilva, Maria-José|||0000-0001-8985-7737
  • Solà, Rosa|||0000-0002-8359-235X
  • Covas Planells, Maria Isabel
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Mayneris-Perxachs, Jordi|||0000-0003-3788-3815
Phenol-rich foods consumption such as virgin olive oil (VOO) has been shown to have beneficial effects on cardiovascular diseases. The broader biochemical impact of VOO and phenol-enriched OOs remains, however, unclear. A randomized, double-blind, cross-over, controlled trial was performed with thirty-three hypercholesterolemic individuals who ingested for 3-weeks (25 mL/day): (1) an OO enriched with its own olive oil phenolic compounds (PCs) (500 ppm; FOO); (2) an OO enriched with its own olive oil PCs (250 ppm) plus thyme PCs (250 ppm; FOOT); and (3) a VOO with low phenolic content (80 ppm). Serum lipid and glycemic profiles, serum 1H-NMR spectroscopy-based metabolomics, endothelial function, blood pressure, and cardiovascular risk were measured. We combined OPLS-DA with machine learning modelling to identify metabolites discrimination of the treatment groups. Both phenol-enriched OO interventions decreased the levels of glutamine, creatinine, creatine, dimethylamine, and histidine in comparison to VOO one. In addition, FOOT decreased the plasma levels of glycine and DMSO2 compared to VOO, while FOO decreased the circulating alanine concentrations but increased the plasma levels of acetone and 3-HB compared to VOO. Based on these findings, phenol-enriched OOs were shown to result in a favorable shift in the circulating metabolic phenotype, inducing a reduction in metabolites associated with cardiometabolic diseases.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes, A randomized, crossover, controlled trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Arranz, Sara|||0000-0003-2397-5145
  • Carrión, Silvia|||0000-0002-1354-2488
  • Subirana, Isaac|||0000-0003-1676-0197
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Blanchart, Gemma|||0000-0003-1965-8235
  • Kool, Marjon
  • Solà, Rosa|||0000-0002-8359-235X
  • Motilva, María José
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Rubió, Laura
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Estruch, Ramón|||0000-0003-1260-4445
  • Covas Planells, Maria Isabel
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Castañer, Olga|||0000-0003-3169-997X
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.